Predicting Progression of Developing Myeloma in a High Risk-Screened Population (PROMISE)

Recruiting
40 years - 75 years
All
Phase N/A
1 Location

Brief description of study

We will further study people who test positive for these early warning signs of multiple myeloma so that we can learn how to prevent them from developing into cancer. 
 
Your participation may help researchers find new ways to prevent and treat blood cancer.
 

Detailed description of study

This study aims to find new ways to prevent and treat blood cancer.

Your participation may help prevent multiple myeloma in future generations.

For more information, please visit the PROMISE study website: https://www.enroll.promisestudy.org/

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: healthy,cancer,multiple mylemoa,myeloma,MGUS,cancer screening,smoldering multiple myeloma,monoclonal gammopathy of undetermined significance,waldentrom macroglobulinemia
  • Age: 40 years - 75 years
  • Gender: All

 
Please take our survey to see if you qualify: PROMISE Eligibility Questionnaire 
 
 

Updated on 04 Aug 2024. Study ID: 18-370

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Zip Code
Please provide your 5-digit zip code
0 0 /250
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team